Rankings
▼
Calendar
NAGE Q4 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$423M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
+18.2% YoY
Gross Profit
$12M
57.2% margin
Operating Income
-$1M
-6.9% margin
Net Income
-$1M
-6.8% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+23.0%
Cash Flow
Operating Cash Flow
-$328,000
Free Cash Flow
-$500,000
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$54M
Total Liabilities
$25M
Stockholders' Equity
$29M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$18M
+18.2%
Gross Profit
$12M
$11M
+10.6%
Operating Income
-$1M
-$5M
+72.8%
Net Income
-$1M
-$5M
+73.4%
← FY 2022
All Quarters
Q1 2023 →